LIFELONG LESSON FROM HBS “The School gave me the ability to have a broad overview that focused not only on the financial dimension of a business but on its many other facets, including management, ...
Almost a decade ago, brain drugmaker Acorda Therapeutics was having a banner year. Its multiple sclerosis medicine Ampyra brought in more money than ever in 2017, reaching nearly $550 million and ...
Ladies and gentlemen, welcome to Acorda Therapeutics' Second Quarter 2022 Financial and Business Update. [Operator Instructions] Please be advised that this call is being recorded at the company's ...
As a venture-capital pioneer and co-founder of Apax Partners, Sir Ronald Cohen experienced firsthand the emergence of an investment framework based on rigorously measured risk and return. How ...
New York State, particularly in and around New York City, possesses an extraordinary concentration of world-class biomedical research and financial institutions, assets that ought to place the state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results